These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 1144773)
1. Package inserts, adverse drug reactions, and the physician's liability. Morrell MX Ration Drug Ther; 1975 Aug; 9(8):1-6. PubMed ID: 1144773 [No Abstract] [Full Text] [Related]
2. The package insert and the pharmacist's liability. Simonsmeier LM Am J Pharm Sci Support Public Health; 1977; 149(3):82-9. PubMed ID: 596428 [No Abstract] [Full Text] [Related]
3. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption. Poser S Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225 [No Abstract] [Full Text] [Related]
4. Some issues related to patient package inserts. Fink JL Hosp Formul; 1979 Feb; 14(2):181-3. PubMed ID: 10240143 [No Abstract] [Full Text] [Related]
5. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule. Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285 [TBL] [Abstract][Full Text] [Related]
6. The patient package insert and its legal implications. Cook D Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797 [No Abstract] [Full Text] [Related]
7. Patient package inserts and the pharmacist's responsibility. Fink JL Am J Hosp Pharm; 1979 Feb; 36(2):226-9. PubMed ID: 420215 [TBL] [Abstract][Full Text] [Related]
8. Black box warnings in prescription drug labeling: results of a survey of 206 drugs. Beach JE; Faich GA; Bormel FG; Sasinowski FJ Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718 [No Abstract] [Full Text] [Related]
9. A means to provide patient education: "Rx package inserts, patient package inserts, device labeling". Sherman M ONA J; 1979 Aug; 6(8):326-9. PubMed ID: 257297 [No Abstract] [Full Text] [Related]
10. Enterprise liability for bad outcomes from drug therapy: the doctor, the hospital, the pharmacy, and the drug firm. Furrow BR Spec Law Dig Health Care Law; 1998 Apr; (229):9-69. PubMed ID: 10178162 [No Abstract] [Full Text] [Related]
11. Prescription drugs; revocation of final guideline patient package inserts and withdrawal of draft guideline patient package inserts--Food and Drug Administration. Notice. Fed Regist; 1982 Sep; 47(173):39249-50. PubMed ID: 10258155 [TBL] [Abstract][Full Text] [Related]
12. Drug reactions: the role of the package insert. Barnett FJ J Leg Med (N Y); 1973; 1(1):19-23. PubMed ID: 4548069 [No Abstract] [Full Text] [Related]
13. The history of patient package inserts in the United States. Moore SR; Morris LA; Groft SC Can Pharm J; 1981 May; 114(5):173-5. PubMed ID: 10251273 [No Abstract] [Full Text] [Related]
14. Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule. Fed Regist; 1981 Jan; 46(1):28. PubMed ID: 10249520 [TBL] [Abstract][Full Text] [Related]
15. The medicolegal aspects of adverse drug reactions. Bernstein HN; Levine AM Int Ophthalmol Clin; 1970; 10(3):455-72. PubMed ID: 5537801 [No Abstract] [Full Text] [Related]
16. The patient package insert--health care provider's friend or foe? Hirsh HL Nurs Homes; 1979; 28(4):24-5. PubMed ID: 10283734 [No Abstract] [Full Text] [Related]
17. Patient package inserts--instructions or intrusions? Harvey MW Leg Aspects Med Pract; 1978 Aug; 6(8):47-51. PubMed ID: 703481 [No Abstract] [Full Text] [Related]
18. The legal status of patient package inserts. Whitman JA Hosp Formul; 1978 Oct; 13(10):789-91. PubMed ID: 10238809 [No Abstract] [Full Text] [Related]